vs
Side-by-side financial comparison of CHART INDUSTRIES INC (GTLS) and Insulet Corporation (PODD). Click either name above to swap in a different company.
CHART INDUSTRIES INC is the larger business by last-quarter revenue ($1.1B vs $783.7M, roughly 1.4× Insulet Corporation). Insulet Corporation runs the higher net margin — 13.0% vs 5.0%, a 8.0% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (31.2% vs -2.5%). CHART INDUSTRIES INC produced more free cash flow last quarter ($66.2M vs $48.2M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs 6.6%).
Oricon Inc. , established in 1999, is the holding company at the head of a Japanese corporate group that supplies statistics and information on music and the music industry in Japan and Western music. It started as Original Confidence Inc. , which was founded by Sōkō Koike in November 1967 and became known for its music charts. Oricon Inc. was originally set up as a subsidiary of Original Confidence and took over the latter's Oricon record charts in April 2002.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
GTLS vs PODD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $783.7M |
| Net Profit | $53.6M | $101.6M |
| Gross Margin | 33.3% | 72.6% |
| Operating Margin | 11.6% | 18.7% |
| Net Margin | 5.0% | 13.0% |
| Revenue YoY | -2.5% | 31.2% |
| Net Profit YoY | -32.7% | 0.9% |
| EPS (diluted) | $1.06 | $1.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $783.7M | ||
| Q3 25 | $1.1B | $706.3M | ||
| Q2 25 | $1.1B | $649.1M | ||
| Q1 25 | $1.0B | $569.0M | ||
| Q4 24 | $1.1B | $597.5M | ||
| Q3 24 | $1.1B | $543.9M | ||
| Q2 24 | $1.0B | $488.5M | ||
| Q1 24 | $950.7M | $441.7M |
| Q4 25 | $53.6M | $101.6M | ||
| Q3 25 | $-138.5M | $87.6M | ||
| Q2 25 | $76.1M | $22.5M | ||
| Q1 25 | $49.5M | $35.4M | ||
| Q4 24 | $79.6M | $100.7M | ||
| Q3 24 | $69.0M | $77.5M | ||
| Q2 24 | $58.6M | $188.6M | ||
| Q1 24 | $11.3M | $51.5M |
| Q4 25 | 33.3% | 72.6% | ||
| Q3 25 | 34.1% | 72.2% | ||
| Q2 25 | 33.6% | 69.7% | ||
| Q1 25 | 33.9% | 71.9% | ||
| Q4 24 | 33.6% | 72.1% | ||
| Q3 24 | 34.1% | 69.3% | ||
| Q2 24 | 33.8% | 67.7% | ||
| Q1 24 | 31.8% | 69.5% |
| Q4 25 | 11.6% | 18.7% | ||
| Q3 25 | -8.0% | 16.7% | ||
| Q2 25 | 15.7% | 18.7% | ||
| Q1 25 | 15.2% | 15.6% | ||
| Q4 24 | 17.0% | 18.3% | ||
| Q3 24 | 16.8% | 16.2% | ||
| Q2 24 | 16.1% | 11.2% | ||
| Q1 24 | 11.9% | 12.9% |
| Q4 25 | 5.0% | 13.0% | ||
| Q3 25 | -12.6% | 12.4% | ||
| Q2 25 | 7.0% | 3.5% | ||
| Q1 25 | 4.9% | 6.2% | ||
| Q4 24 | 7.2% | 16.9% | ||
| Q3 24 | 6.5% | 14.2% | ||
| Q2 24 | 5.6% | 38.6% | ||
| Q1 24 | 1.2% | 11.7% |
| Q4 25 | $1.06 | $1.42 | ||
| Q3 25 | $-3.23 | $1.24 | ||
| Q2 25 | $1.53 | $0.32 | ||
| Q1 25 | $0.94 | $0.50 | ||
| Q4 24 | $1.57 | $1.38 | ||
| Q3 24 | $1.33 | $1.08 | ||
| Q2 24 | $1.10 | $2.59 | ||
| Q1 24 | $0.10 | $0.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $366.0M | — |
| Total DebtLower is stronger | $3.7B | $930.8M |
| Stockholders' EquityBook value | $3.2B | $1.5B |
| Total Assets | $9.8B | $3.2B |
| Debt / EquityLower = less leverage | 1.13× | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $366.0M | — | ||
| Q3 25 | $399.2M | — | ||
| Q2 25 | $342.3M | — | ||
| Q1 25 | $296.2M | — | ||
| Q4 24 | $308.6M | — | ||
| Q3 24 | $310.2M | — | ||
| Q2 24 | $247.4M | — | ||
| Q1 24 | $191.9M | — |
| Q4 25 | $3.7B | $930.8M | ||
| Q3 25 | — | $934.9M | ||
| Q2 25 | — | $939.0M | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | $3.8B | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $3.2B | $1.5B | ||
| Q3 25 | $3.2B | $1.4B | ||
| Q2 25 | $3.4B | $1.5B | ||
| Q1 25 | $3.0B | $1.3B | ||
| Q4 24 | $2.8B | $1.2B | ||
| Q3 24 | $3.0B | $1.1B | ||
| Q2 24 | $2.7B | $998.4M | ||
| Q1 24 | $2.7B | $790.7M |
| Q4 25 | $9.8B | $3.2B | ||
| Q3 25 | $9.8B | $3.0B | ||
| Q2 25 | $9.7B | $3.5B | ||
| Q1 25 | $9.3B | $3.5B | ||
| Q4 24 | $9.1B | $3.1B | ||
| Q3 24 | $9.5B | $3.0B | ||
| Q2 24 | $9.3B | $2.9B | ||
| Q1 24 | $9.2B | $2.6B |
| Q4 25 | 1.13× | 0.61× | ||
| Q3 25 | — | 0.68× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 1.33× | 1.07× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | — | 1.36× | ||
| Q1 24 | — | 1.72× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $88.8M | $183.3M |
| Free Cash FlowOCF − Capex | $66.2M | $48.2M |
| FCF MarginFCF / Revenue | 6.1% | 6.2% |
| Capex IntensityCapex / Revenue | 2.1% | 17.2% |
| Cash ConversionOCF / Net Profit | 1.66× | 1.80× |
| TTM Free Cash FlowTrailing 4 quarters | $202.8M | $377.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $88.8M | $183.3M | ||
| Q3 25 | $118.0M | $125.7M | ||
| Q2 25 | $145.9M | $196.5M | ||
| Q1 25 | $-60.0M | $63.8M | ||
| Q4 24 | $281.4M | $147.7M | ||
| Q3 24 | $200.6M | $98.5M | ||
| Q2 24 | $116.1M | $96.5M | ||
| Q1 24 | $-95.1M | $87.6M |
| Q4 25 | $66.2M | $48.2M | ||
| Q3 25 | $94.7M | $100.1M | ||
| Q2 25 | $122.0M | $177.9M | ||
| Q1 25 | $-80.1M | $51.5M | ||
| Q4 24 | $260.9M | $94.1M | ||
| Q3 24 | $174.5M | $71.8M | ||
| Q2 24 | $88.0M | $74.0M | ||
| Q1 24 | $-141.2M | $65.5M |
| Q4 25 | 6.1% | 6.2% | ||
| Q3 25 | 8.6% | 14.2% | ||
| Q2 25 | 11.3% | 27.4% | ||
| Q1 25 | -8.0% | 9.1% | ||
| Q4 24 | 23.6% | 15.7% | ||
| Q3 24 | 16.4% | 13.2% | ||
| Q2 24 | 8.5% | 15.1% | ||
| Q1 24 | -14.9% | 14.8% |
| Q4 25 | 2.1% | 17.2% | ||
| Q3 25 | 2.1% | 3.6% | ||
| Q2 25 | 2.2% | 2.9% | ||
| Q1 25 | 2.0% | 2.2% | ||
| Q4 24 | 1.9% | 9.0% | ||
| Q3 24 | 2.5% | 4.9% | ||
| Q2 24 | 2.7% | 4.6% | ||
| Q1 24 | 4.8% | 5.0% |
| Q4 25 | 1.66× | 1.80× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | 1.92× | 8.73× | ||
| Q1 25 | -1.21× | 1.80× | ||
| Q4 24 | 3.54× | 1.47× | ||
| Q3 24 | 2.91× | 1.27× | ||
| Q2 24 | 1.98× | 0.51× | ||
| Q1 24 | -8.42× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GTLS
| Repair Service And Leasing Segment | $330.4M | 31% |
| Heat Transfer Systems Segment | $325.8M | 30% |
| Specialty Products Segment | $259.5M | 24% |
| Transferred Over Time | $94.4M | 9% |
| Transferred At Point In Time | $69.5M | 6% |
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
